Coronary Microvascular Dysfunction

Par : Filippo Crea, Gaetano Lanza, Paolo Camici

Formats :

    • PrésentationCartonné
    • Poids0.585 kg
    • Dimensions15,9 cm × 24,1 cm × 1,7 cm
    • ISBN978-88-470-5366-3
    • EAN9788847053663
    • Date de parution10/09/2013
    • ÉditeurSpringer

    Résumé

    In the past two decades a number of studies have shown that abnormalities in the function and structure of coronary microcirculation can be detected in several cardiovascular diseases.�On the basis of the clinical setting in which it occurs, coronary microvascular dysfunction (CMD) can be classified into four types: CMD in the absence of any other cardiac disease; CMD in myocardial diseases; CMD in obstructive epicardial coronary artery disease; and iatrogenic CMD.
    In some instances�CMD represents an epiphenomenon, whereas in others it represents an important�marker of risk or may contribute to the pathogenesis of myocardial ischemia,�thus becoming a possible therapeutic target.�This book provides an update on coronary�physiology�and a systematic assessment of microvascular abnormalities in cardiovascular diseases,�in the hope that it will assist clinicians in prevention, detection�and management of CMD in their everyday activity.
    In the past two decades a number of studies have shown that abnormalities in the function and structure of coronary microcirculation can be detected in several cardiovascular diseases.�On the basis of the clinical setting in which it occurs, coronary microvascular dysfunction (CMD) can be classified into four types: CMD in the absence of any other cardiac disease; CMD in myocardial diseases; CMD in obstructive epicardial coronary artery disease; and iatrogenic CMD.
    In some instances�CMD represents an epiphenomenon, whereas in others it represents an important�marker of risk or may contribute to the pathogenesis of myocardial ischemia,�thus becoming a possible therapeutic target.�This book provides an update on coronary�physiology�and a systematic assessment of microvascular abnormalities in cardiovascular diseases,�in the hope that it will assist clinicians in prevention, detection�and management of CMD in their everyday activity.